Justification for Application of Recombinant Superoxide Dismutase in the Ozone/NOUltrasound Technology for Wound Treatment in Oncological Patients

This paper justifies application of the recombinant superoxide dismutase product “Rexod” as one of the active components used in implementation of the ozone/NO-ultrasound technologies for treatment of complicated postoperative wounds in oncological patients. The theoretical research has shown that it is necessary to take into account biochemical reaction kinetics with involvement of oxygen active forms, oxygen radicals and nitric oxides interacting with biological substrates of the organism in oxidizing stress conditions, when dealing with pathological wound process and implementation of ozone/NO-ultrasound technologies.